Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells
- PMID: 3855287
Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells
Abstract
Previous work has shown that 6-thioguanine (TGua) is an effective inducer of differentiation of Friend and HL-60 leukemia cells which lack hypoxanthine-guanine phosphoribosyltransferase but is at best only weakly active in inducing maturation in parental wild-type cells. Studies in wild-type and mutant HL-60 cells have provided evidence that the free-base TGua is the form of this drug that induces differentiation, while the formation of TGua nucleotides leads to cytotoxicity and inhibits differentiation. To attempt to increase the potential of TGua to serve as an inducer of parental HL-60 leukemia cells, physiological purine and pyrimidine nucleosides were tested for their ability to protect HL-60 cells against TGua-induced cytotoxicity. Adenosine, deoxyadenosine, inosine, and deoxyinosine completely prevented the toxic action of the purinethiol, while guanosine and deoxyguanosine were only partially effective. The capacity of adenosine and deoxyadenosine to prevent the cytotoxicity of TGua was abolished by the inhibitor of adenosine deaminase, deoxycoformycin, implying that inosine and deoxyinosine were the active forms of the protecting agents. The protective activities of inosine and deoxyinosine appeared to depend on phosphorolysis catalyzed by purine nucleoside phosphorylase, since exogenously added hypoxanthine was as effective as inosine in reducing the cytotoxicity of the purine antimetabolite. Accumulation of TGua nucleotides in the acid-soluble fraction of HL-60 cells treated with TGua was significantly decreased by the presence of inosine. Inosine also served under these circumstances as a D-ribose 1-phosphate donor to TGua, as evidenced by its increased conversion to 6-thioguanosine. The prevention of the cytotoxicity of TGua by the simultaneous administration of hypoxanthine or its nucleosides resulted in an expression of the differentiation-inducing properties of TGua in HL-60 cells, as measured by the accumulation of nitroblue tetrazolium-positive cells. These findings support the concept that the processes of cytotoxicity and differentiation are separable events produced by different metabolic forms of the purine antimetabolite.
Similar articles
-
Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.J Cell Physiol. 1984 Nov;121(2):383-90. doi: 10.1002/jcp.1041210216. J Cell Physiol. 1984. PMID: 6593322
-
The role of benzodiazepine receptors in the induction of differentiation of HL-60 leukemia cells by benzodiazepines and purines.J Cell Physiol. 1987 May;131(2):226-34. doi: 10.1002/jcp.1041310212. J Cell Physiol. 1987. PMID: 3034922
-
Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.Cancer Res. 1984 Sep;44(9):3679-85. Cancer Res. 1984. PMID: 6589043
-
Induction of leukemia cell differentiation by chemotherapeutic agents.Adv Enzyme Regul. 1983;21:3-20. doi: 10.1016/0065-2571(83)90005-5. Adv Enzyme Regul. 1983. PMID: 6400065 Review.
-
Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites.Curr Pharm Des. 2003;9(31):2627-42. doi: 10.2174/1381612033453677. Curr Pharm Des. 2003. PMID: 14529546 Review.
Cited by
-
Queuine Micronutrient Deficiency Promotes Warburg Metabolism and Reversal of the Mitochondrial ATP Synthase in Hela Cells.Nutrients. 2020 Mar 24;12(3):871. doi: 10.3390/nu12030871. Nutrients. 2020. PMID: 32213952 Free PMC article.
-
The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.Br J Cancer. 1985 Sep;52(3):293-302. doi: 10.1038/bjc.1985.193. Br J Cancer. 1985. PMID: 3899154 Free PMC article. Review.
-
Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA.Mol Cell Biol. 1987 Oct;7(10):3613-9. doi: 10.1128/mcb.7.10.3613-3619.1987. Mol Cell Biol. 1987. PMID: 3479681 Free PMC article.
-
Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.Br J Cancer. 1998;77(1):33-9. doi: 10.1038/bjc.1998.6. Br J Cancer. 1998. PMID: 9459143 Free PMC article.
-
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.Nucleic Acids Res. 2017 Feb 28;45(4):2029-2039. doi: 10.1093/nar/gkw847. Nucleic Acids Res. 2017. PMID: 28204548 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials